Tower Research Capital (TRC)’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74K | Sell |
9,073
-474
| -5% | -$143 | ﹤0.01% | 4601 |
|
|
2025
Q1 | $2.72K | Sell |
9,547
-3,845
| -29% | -$1.1K | ﹤0.01% | 4516 |
|
|
2024
Q4 | $7.86K | Buy |
13,392
+8,277
| +162% | +$4.86K | ﹤0.01% | 4035 |
|
|
2024
Q3 | $2.28K | Buy |
+5,115
| New | +$2.28K | ﹤0.01% | 5016 |
|
|
2024
Q2 | – | Sell |
-4,559
| Closed | -$12.5K | – | 5678 |
|
|
2024
Q1 | $12.5K | Buy |
4,559
+4,248
| +1,366% | +$11.6K | ﹤0.01% | 3476 |
|
|
2023
Q4 | $756 | Buy |
311
+149
| +92% | +$362 | ﹤0.01% | 5501 |
|
|
2023
Q3 | $327 | Buy |
+162
| New | +$327 | ﹤0.01% | 5603 |
|
|
2023
Q2 | – | Sell |
-8,821
| Closed | -$22K | – | 6007 |
|
|
2023
Q1 | $22K | Sell |
8,821
-13,145
| -60% | -$32.8K | ﹤0.01% | 3315 |
|
|
2022
Q4 | $70K | Buy |
21,966
+3,975
| +22% | +$12.7K | ﹤0.01% | 2102 |
|
|
2022
Q3 | $53K | Buy |
17,991
+16,105
| +854% | +$47.4K | ﹤0.01% | 3108 |
|
|
2022
Q2 | $6K | Buy |
1,886
+510
| +37% | +$1.62K | ﹤0.01% | 4890 |
|
|
2022
Q1 | $19K | Buy |
1,376
+627
| +84% | +$8.66K | ﹤0.01% | 3566 |
|
|
2021
Q4 | $10K | Sell |
749
-2,713
| -78% | -$36.2K | ﹤0.01% | 4529 |
|
|
2021
Q3 | $33K | Buy |
3,462
+758
| +28% | +$7.23K | ﹤0.01% | 3280 |
|
|
2021
Q2 | $28K | Buy |
2,704
+1,597
| +144% | +$16.5K | ﹤0.01% | 3559 |
|
|
2021
Q1 | $20K | Buy |
1,107
+700
| +172% | +$12.6K | ﹤0.01% | 3870 |
|
|
2020
Q4 | $14K | Buy |
+407
| New | +$14K | ﹤0.01% | 4086 |
|